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Abstract
Aims: To examine changes and explanatory variables for changes in health-related
quality of life in patients treated with long-term mechanical ventilation over a 6-year
period.
Background: Long-term mechanical ventilation is a treatment for individuals with
chronic hypercapnic respiratory failure, primarily caused by neuromuscular diseases,
obesity hypoventilation syndrome, chronic obstructive pulmonary and restrictive
thoracic diseases. Studies on long-term outcome on health-related quality of life
and factors influencing it are lacking.
Design: Prospective cohort study.
Methods: Data were collected from the Norwegian Long-Term-Mechanical-Ventila-
tion Registry and from patient-reported questionnaire in 2008 and 2014. Health-
related quality of life was measured by the Severe Respiratory Insufficiency
questionnaire, containing 49 items and seven subdomains. Linear mixed effects
models were used to measure changes and identify factors for changes.
Results: After 6 years, 60 patients were still participating, out of 127 at baseline.
Health-related quality of life improved significantly in the total score and in four sub-
domains of the questionnaire. Satisfaction with training in long-term mechanical venti-
lation was an explanatory variable for improved ‘psychological well-being’ and follow-
up for improvement of ‘anxiety’. Side effects of the treatment like facial soreness were
associated with the total score. High age and high forced vital capacity were related
to lower ‘physical function’ and improved ‘social functioning’, respectively.
Conclusion: Long-term mechanical ventilation over 6 years improved health-related
quality of life in most patients. Patient training, follow-up and reduction of side
effects, largely delivered by trained nurses, contribute to achieve the main goal of
the treatment—improved health-related quality of life.
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1 | INTRODUCTION
Long-term mechanical ventilation (LTMV) is a treatment used for
individuals with chronic hypercapnic respiratory failure (CHRF) pri-
marily caused by neuromuscular diseases (NMD), obesity hypoventi-
lation syndrome (OHS), chronic obstructive pulmonary disease
(COPD) and restrictive thoracic disorders (RTD) (Windisch, 2008).
LTMV is defined as non-invasive ventilation using a mask or mouth-
piece, or invasive ventilation using a tracheostomy for a period of at
least 3 months on a daily basis and the treatment is carried out
mainly in the user’s home or at a long-term care facility (Lloyd-Owen
et al., 2005). The estimated prevalence of LTMV in Norway and Eur-
ope is 37 and 6.6 per 100,000 respectively (Norwegian LTMV Regis-
try 2016, Lloyd-Owen et al., 2005).
Most individuals treated with LTMV have incurable and often
chronically progressive diseases (Huttmann & Windisch, 2015; p.
277). Without LTMV, individuals with CHRF have severely impaired
health-related quality of life (HRQoL) (Dellborg et al., 2002), but
LTMV might have an impact on daily life (Brooks et al., 2004; Lin-
dahl, Sandmann, & Rasmussen, 2005) and lifelong follow-up from
the healthcare service is needed (Leasa & Elson, 2016). Improving or
maintaining HRQoL is one of the main goals both in invasively venti-
lated (AARC, 2007) and in non-invasively ventilated individuals
(McKim et al., 2011).
1.1 | Background
The knowledge about how LTMV has an impact on HRQoL, has
increased, but is still patchy (MacIntyre, Asadi, Mckim, & Bagshaw,
2016; Simonds, 2016). Certain aspects of HRQoL are well docu-
mented while others are poorly investigated. Knowledge from quali-
tative studies found that LTMV gave more energy to cope with daily
life (Ballangrud, Bogsti, & Johansson, 2009) and young men with
Duchenne muscular dystrophy (DMD) reported that acquiring a ven-
tilator enabled them to make a new positive start to life (Dreyer,
Steffensen, & Pedersen, 2010).
In a discussion paper on quality of life, Moons, Budts, and De
Geest (2006) found that quality of life was an umbrella term, cover-
ing different other concepts such as HRQoL, health status, symp-
toms and happiness (Moons et al., 2006). As a result, research under
the heading of quality of life may cover similar, but still different
concepts. In clinical research, the term HRQoL is widely used, but as
this term also is lacking in conceptual clarity, previous research is
based on many different measures. According to Windisch (2008),
the concept of HRQoL has many components and covers aspects of
self-reported physical health, psychological well-being, social rela-
tions and functional capacities. Following a comprehensive method-
ological process, including patients treated with LTMV, the Severe
Respiratory Insufficiency (SRI) questionnaire was developed, specific
for measuring HRQoL in LTMV patients (Windisch et al., 2003). Con-
dition-specific questionnaires are more tailored and responsive than
generic questionnaires towards problems of particular importance to
the target group of patients (Fayers & Machin, 2016, p. 118). The
Why is this research/review needed?
• The main goal with long-term mechanical ventilation is to
increase or maintain health-related quality of life. People
suffering from chronic hypercapnic respiratory failure not
treated with long-term mechanical ventilation have
severely impaired health-related quality of life.
• The knowledge of how long-term mechanical ventilation
has an impact on health-related quality of life is poor and
there are even fewer studies on which factors influence
changes in it over several years.
• Previous studies measuring health-related quality of life in
patient treated with long-term mechanical ventilation have
most often used questionnaires not specific for this group.
The validated Severe Respiratory Insufficiency question-
naire has been developed for and together with this group
of patients, but not yet used in a long-term follow-up study.
What are the key findings?
• Six-year follow-up study of patients treated with long-
term mechanical ventilation found improved health-
related quality of life measured by the specific and vali-
dated Severe Respiratory Insufficiency questionnaire.
• The improvements were in the total score of the question-
naire and in the domains reflecting anxiety related to
breathing, contact and relationships with other people and
the ability to cope with their condition and overall satisfac-
tion with life.
• Patient-reported satisfaction with training and follow-up
from healthcare professionals were factors that con-
tributed to improved health-related quality of life in this
group. Side effects from non-invasive ventilation inter-
acted with change in the total SRI score. High forced
vital capacity from lung function measurements was a
factor for improvements in the social functioning domain
and high age was an explanatory factor for reduced score
the physical function domain.
How should the findings be used to influence
policy/practice/research/education?
• The findings add valuable new knowledge in the field of
respiratory care and should be included in the current
curriculum for healthcare professionals. The study out-
comes are important to decision-making both at the indi-
vidual level concerning treatment options and in terms of
planning of healthcare services for patients treated with
long-term mechanical ventilation.
• Nurses interact with long-term mechanical ventilation
patients in the outpatient clinic, in hospital wards and
through home care and are in a unique position to offer sys-
tematic patient training, prevent or reduce side effects of
non-invasive ventilation and ensure that patients receive
realistic information about possible side effects.
• We recommend further prospective international multicen-
tre studies on the link between long-term mechanical venti-
lation and health-related quality of life aspects, including on
intervention models for training and follow-up in this group
of patients by including them as members of the multidisci-
plinary team and use of patient-reported and registry data
to improve care and health-related quality of life.
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scientific framework for the concept of HRQoL in the present study
was therefore based on research that used the SRI questionnaire in
patients treated with LTMV.
Applying the SRI questionnaire, a 1-year follow-up study found
significant improvements amongst patients with CHRF in a mixed
study population including NMD, OHS, RTD and COPD. HRQoL
improved after 1 month of LTMV and the results remained stable at
the elevated level during the following year (Windisch, 2008). Two
randomized controlled trials (RCT) reported significant improvements
in the SRI scores 1 year after initiating LTMV in patients with severe
COPD (K€ohnlein et al., 2014; Struik et al., 2014). Still, there is an
ongoing discussion regarding the indication and benefit of LTMV in
COPD patients (Simonds, 2016).
We have been unable to identify studies using a questionnaire
specific to patients treated with LTMV in a follow-up study over
more than 1 year, or studies focusing on the efficacy of ongoing
LTMV over several years. However, some sociodemographic and
clinical variables associated with HRQoL measured with the SRI
questionnaire have been identified. Men had poorer HRQoL scores
in the ‘respiratory complaints’ and ‘anxiety’ domains compared with
women (Lopez-Campos et al., 2008). The underlying disease was an
explanatory variable for change in the single domains of the SRI, as
significant improvements in ‘physical function’ were evident only in
patients with COPD and RTD. The largest improvements were
observed in NMD and OHS patients in the ‘attendant symptoms and
sleep’ domain (Windisch, 2008). Co-morbidity was more prevalent in
older patients with COPD, reducing their SRI score compared with
younger patients with NMD (Huttmann, Windisch, & Storre, 2015).
The physiological efficacy of the LTMV treatment is to decrease the
work of breathing and support gas exchange (Georgopoulo, 2013).
However, ventilation modes and additional long-term oxygen ther-
apy were not associated with HRQoL (Budweiser et al., 2007) and
ventilator settings in obese patients had no influence on change in
HRQoL assessed by the SRI questionnaire (Murphy et al., 2012;
Storre et al., 2006). Furthermore, the most common criteria generally
used to examine the severity of CHRF are the physiological mea-
surements, partial pressure of carbon dioxide (pCO2) and forced vital
capacity (FVC) (Simonds, 2016).
These physiological measurements do not reflect the perceptions
and subjective state of the patient, but correlations have been
reported between these physical measurements and the physical
aspects of HRQoL (Hahn et al., 2007). High ventilator pressure set-
tings, aiming to reduce levels of pCO2, were also proposed as the
explanation for improved SRI scores in individuals with COPD
(K€ohnlein et al., 2014).
Some aspects of HRQoL in LTMV are well documented. How-
ever, there are certain areas especially relevant for nurses that have
only been incompletely investigated. LTMV can be time-consuming
and costly and may contribute to significant side effects. If LTMV
increases the burden of disease without any positive effects on
HRQoL, it would raise ethical concerns (Windisch, 2010 p. 582). Fex,
Flensner, Ek, and S€oderhamn (2012) recommended supplementary
nursing support for people using advanced medical technology at
home. Good HRQoL in individuals receiving LTMV depends on good
care being provided by competent healthcare personnel (Brooks
et al., 2004; Lindahl et al., 2005). However, shortcomings in the
information and follow-up provided by healthcare staff have been
reported. Access to better trained personnel has been requested by
LTMV patients (Chang, Marsh, Smith, & Neill, 2010), who suffer from
severe conditions requiring information, support and long-term care
to enjoy the best quality of life available (Leasa & Elson, 2016).
There is limited knowledge of how indicators like side effects of the
treatment, satisfaction with LTMV training and follow-up might
influence changes in HRQoL.
2 | THE STUDY
2.1 | Aims
The objectives of the present study were as follows:
• to examine changes in HRQoL in patients treated with LTMV
from 2008-2014.
• To examine sociodemographic, clinical and patient-reported
explanatory variables associated with changes in HRQoL in this
group.
2.2 | Design
The research design was a prospective cohort study.
2.3 | Participants
In 2008, all patients aged ≥18 years in the Norwegian national
LTMV registry in Western Norway were invited to participate in the
study. The inclusion criteria were patients treated with non-invasive
or invasive LTMV for at least 3 months who were mentally able to
answer questions. Those who agreed to participate were followed
until 2014.
2.4 | Data collection
Data collection included clinical variables from the LTMV registry as
well as patient-reported clinical information from questionnaires at
the start of the study in 2008 and at its end in 2014. At the start,
an information letter, the baseline questionnaires and a stamped
return envelope were sent by mail. The follow-up (2014) question-
naires were completed when the patients attended their regular con-
sultation in the outpatient clinic at the two university hospitals in
Western Norway.
2.4.1 | Norwegian registry for LTMV
The LTMV registry was established in 2002 and formally approved
as a national medical quality registry 10 years later. The main pur-
pose of the registry is monitoring LTMV to promote geographic
equality, quality assurance, professional development, research and
resource planning. Patients permanently dependent on non-invasive
MARKUSSEN ET AL. | 653
or invasive LTMV during all or part of the day are included. There is
a written consent to participate in the registry and it is possible for
individuals to withdraw from the register. The national coverage
ratio in the registry was 72% in 2016 (Norwegian LTMV Registry
2016). Data collected to the present study from the LTMV registry
were sociodemographic data, the date and main diagnosis when
starting LTMV, the type of connection to the ventilator, blood gas
analyses and spirometry values.
2.4.2 | Explanatory variable for changes in HRQoL
Changes in HRQoL were examined according to baseline characteris-
tics measured in 2008. The background variables used were: sex;
age; education; marital status and disease. The potential explanatory
variable for changes in HRQoL included: number of years treated
with LTMV; pCO2 and FVC. Patient-reported explanatory variable
for changes in HRQoL included hours a day on LTMV, a yes/no
question regarding whether they experienced any side effects, with
further follow-up questions on which side effects, where they were
given the following options: air leakage from the mask; soreness
caused by mask pressure; condensation inside the mask; and an
option to describe other side effects in their own words. Depen-
dency on daily assistance with using the ventilator was measured by
one yes/no question. Patient satisfaction with the follow-up from
specialist healthcare professionals consisted of one statement
(“Received adequate follow-up”) as did patient satisfaction with
training in the use of LTMV (“Received adequate training in LTMV”),
both of which had five response categories ranging from “Strongly
disagree”—“Strongly agree”.
2.4.3 | Study setting: Clinical follow-up from
healthcare professionals
Clinical follow-up for LTMV patients is organized through a national
multi and interdisciplinary competence network. The network is
coordinated by a physician and includes specially trained nurses and
physiotherapists, specialists in neurology and general practitioners. It
also includes a liaison nurse who plays an important role when the
patient is transferred from hospital to their home with a ventilator,
both in terms of educating the caregiver team and promoting con-
tact with relatives and caregivers in the community. Follow-up visits
take place 1 to 4 times a year depending on individual circumstances
such as medical condition and psychosocial factors.
2.4.4 | Outcome variable of the study
The outcome variable in the present study was HRQoL, measured
by the SRI questionnaire at baseline (2008) and follow-up (2014).
This is a specific, multidimensional questionnaire covering physical,
psychological and social functioning and was originally developed for
and together with patients receiving LTMV to obtain subjective
descriptions of issues that were important in their daily lives. The
questionnaire contains 49 items and is divided into seven
subdomains. High summary scale values (range 0–100) indicate a
better HRQoL and the subscales are as follows:
SRI-Respiratory Complaints contains eight items relating to dysp-
noea at rest and during physical activity. It covers how often breath-
lessness occurs and the degree of waking up with breathlessness at
night. Breathlessness during speaking, eating and problems with
coughing or mucus in the airways are included in this subdomain.
SRI-Physical Function consists of six items and includes the
patient’s ability to execute everyday physical activities, such as get-
ting dressed, walking stairs and doing housework. Participation in
physical leisure activities and how breathing problems have an
impact on activities are covered by this subdomain.
SRI-Attendant Symptoms and Sleep contains seven items address-
ing the quality of sleep, measured by patient-reported waking up
during the night, problems with falling asleep and general interrup-
tions of sleep. Daytime tiredness, dizziness and headaches are also
covered by this subdomain.
SRI-Anxiety consists of five items including experiences of feeling
anxious about having attacks of dyspnoea and about suffering dysp-
noea at night. Avoiding situations that are stressful due to breathing
difficulties and being worried that the disease will get worse are also
included in this subdomain.
SRI-Social Relationships contains six items including having friends
and feeling comfortable in the company of other people or feeling
lonely and isolated. The disease burden on family life is also covered
in the subscore.
SRI-Social Functioning consists of eight items including the degree
of broken contact with friends and acquaintances. Limited leisure
opportunities, ability to attend social events and the impact of the
disease on marriage or relationships are covered by this subdomain.
SRI-Psychological Well-Being includes nine items covering the
patient’s ability to cope with the disease. The degree of sadness and
overall satisfaction with life are included. Each item belongs to only
one subscale and all items are rated on a five-point Likert scale from
“strongly agree” to “strongly disagree”.
Questions refer to the patient’s health status during the previous
week. The summary scale was obtained by calculating the mean of
the values of each scale (Windisch et al., 2003). However, the mini-
mal clinically important difference of the SRI questionnaire has not
been defined.
2.5 | Ethical considerations
The study was approved by the Norwegian Committee of Ethics in
Medicine, Region III and by the Norwegian Centre for Research Data
(project number 16001). In the Information letter, to the patients in
2008 it was informed that the data were stored for 10 years for a
possible follow-up study and returning the questionnaires by mail
were considered consent to participate in the study. One reminder
letter was sent (Markussen, Lehmann, Nilsen, & Natvig, 2015). Prior
to the follow-up study in 2014, the patients received a new informa-
tion letter about the follow-up study. There was a written consent
to participate in the follow-up study. It was possible for the patients
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to decline from participation in the study, but still be a part in the
register.
2.6 | Data analysis
All statistical analyses were carried out using SPSS version 20 (SPSS
Inc., Chicago, IL, USA) and Stata SE 14 (StataCorp LP, College Sta-
tion, TX, USA) for Windows. Descriptive statistics were used to
quantify sample characteristics. The items in the SRI were recoded
and summarized following the guidelines of the original SRI ques-
tionnaire (Windisch et al., 2003). All statistical tests were two-tailed
and p values lower than.05 were considered as statistically signifi-
cant.
To estimate changes in the seven SRI domains from the start of
the study in 2008 to its end in 2014, we used linear mixed effects
models. All models defined the time-period as a fixed effect,
whereas a random intercept for the individual was specified to
account for correlated observations of the same individual (an
exchangeable correlation structure was assumed). Further, to identify
explanatory variables associated with change in the seven SRI
domains from 2008 - 2014, we extended the abovementioned
models to include the relevant explanatory variables and the product
between the explanatory variable and time-period (i.e. an explana-
tory variable-by-time interaction) as model terms.
Estimated mean changes in the SRI domains from 2008 to 2014
in categories of explanatory variables were reported using regression
model coefficients (b) with 95% confidence intervals (CIs) and p val-
ues. To obtain p values for explanatory variables associated with SRI
change, we used the likelihood ratio test, i.e. comparing the log-like-
lihood between models with and without the explanatory variables -
by-time interaction term. Analyses were adjusted for the following
background variables: sex; age; education; marital status; years on
LTMV and disease.
2.7 | Validity, reliability and rigour
Validity and reliability in quality of life research has been discussed
(Macduff, 2000; Moons et al., 2006). Good validity and international
relevance of this study is provided by using the SRI questionnaire,
that has shown very good psychometric qualities and has been pro-
fessionally adapted and translated into several languages (Duiverman,
Wempe, Bladder, Kerstjens, & Wijkstra, 2008; Ghosh, Rzehak, Elliott,
2008: Potential patientsin the
Norwegian Registry of LTMV
(N = 211)
Excluded patients because 
they did not meet the 
inclusion criteria (N = 18)






Not able to 
contact (N = 1)
Died (N = 52)
Follow-up study-sample 
(N = 60)
2014: The six years follow-up
Not using 
LTMV (N = 8)
Non-responderes (N = 3)
Not able to respond
(N = 3)
Potential responders (N = 63)
F IGURE 1 Flow diagram of the long-
term mechanical ventilation (LTMV)
patients from 2008 to 2014
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& Windisch, 2012; Huttmann et al., 2015, p. 280; Lopez-Campos
et al., 2008; MacIntyre et al., 2016; Markussen et al., 2015; Oga
et al., 2017; Ribeiro, Ferreira, Conde, Oliveira, & Windisch, 2017;
Struik et al., 2013; Windisch, 2008; Windisch et al., 2003). Reliability
and rigour are provided through high-quality clinical data from the
LTMV registry.
3 | RESULTS
3.1 | Study population
Of 193 potential responders in the LTMV registry, 127 (65.8%)
patients agreed to participate and completed the SRI questionnaire
at baseline in 2008 (Figure 1). Of the 127 individuals eligible for fol-
low-up in 2014, 52 had died during the 6-year period. Additionally,
15 patients were excluded for the following reasons: dementia or
unable to answer the questionnaire (N = 3); stopped using LTMV
(N = 8); unable to make contact (N = 1); and did not want to partici-
pate in follow-up study (N = 3). These exclusions related to the dis-
ease groups NMD (N = 6), COPD (N = 2), OHS (N = 6) and RTD
(N = 1), leaving a final study sample of 60 (95%) patients (Figure 1),
ranged in age from 18 to 85 years at inclusion in 2008. The majority
of the patients lived in their own home, only five of the patients
lived in nursing homes.
3.2 | Clinical characteristics
Before LTMV treatment (at least 3 months before the start of the
study), the mean blood value of daytime carbon dioxide (PaCO2 kPa)
and oxygen (PaO2 kPa) was 6.7 (standard deviation [SD] 1.9) and 9.1
(SD 1.7), respectively. In 2008, the mean respirator inspiratory posi-
tive airway pressure (IPAP) was 15.5 cmH2O (SD 2.8) and the expira-
tory pressure (EPAP) was 6.9 cmH2O (SD 2.7) (N = 45). Non-invasive
ventilation (NIV) was the main ventilation mode, only 2 of the sur-
viving patients in 2014 had tracheostomy interface. No patients
used a mouthpiece or helmet as an interface for LTMV. Side effects
from the non-invasive LTMV were reported by 29 individuals
(Table 1). The most common side effects were air leakage between
the face and the mask (N = 21) and soreness caused by mask pres-
sure (N = 10). Other patient-reported side effects were condensation
inside the mask (N = 5), dry nose and mouth (N = 2), eye irritation,
ventilator noise and patient-ventilator synchronization problem
(N = 1). Three people reported three different kind of side effects,
five individuals reported two different side effects, while most indi-
viduals reported one single side effect (N = 21).
3.3 | Change in HRQoL from 2008 to 2014
There were statistically significant improvements in the total SRI
score at mean 4.74 (p = .005) and in four subdomains: SRI-Anxiety,
SRI-Social Functioning, SRI-Social Relationships and SRI-Psychologi-
cal Well-Being. The largest improvement was observed for the Social
Relationships domain, with an improvement of 8.47 (p = .001)
(Table 2) (Table S5). The improvements in the total score of SRI
were seen in all disease groups, except in patients with COPD
(Table 3), who also had a reduction in five of seven SRI subdomains
(Table 4) (Table S1–S4).
TABLE 1 Baseline characteristic of the surviving individuals
treated with LTMV in the longitudinal study
Characteristic N Baseline 2008
Background
Sex, male (n, %) 60 32 (53.3)
Age, years (M, SD) 60 58.0 (15.5)
Education (n, %)
Primary school 60 18 (30.0)
High school 60 23 (38.3)
College/University 60 19 (31.7)
Marital status (n, %)
Married/cohabiting 60 34 (56.7)
Single/divorced/widowed 60 26 (43.3)
Years of LTMV (M, SD) 60 5.23 (4.0)
Disease (n, %)
NMDa 60 26 (43.3)
COPD 60 6 (10.0)
OHS 60 22 (36.7)
RTD 60 6 (10.0)
Treatment
LTMV h/day (n, %)b
5–8 58 33 (56.9)
8–24 58 25 (43.1)
Dependency of daily assistance (n, %) 59 16 (27.1)
Side effects of non-invasive LTMV (n, %) 58 29 (50.9)
Satisfactions with LTMV training (n, %)c
Some satisfaction 59 9 (15.5)
Quite satisfied 59 18 (30.5)
Very satisfied 59 32 (54.2)
Satisfactions with follow-up (n, %)c
Some satisfaction 49 8 (16.3)
Quite satisfied 49 13 (26.5)
Very satisfied 49 28 (57.1)
Respiratory
FVC (litre) (M, SD) 47 2.09 (1.07)
PaCO2 kPa daytime (M, SD) 47 5.66 (0.86)
PaO2, kPa daytime (M, SD) 44 10.3 (1.63)
SD, standard deviation; LTMV, long-term mechanical ventilation; NMD,
neuro muscular disease; COPD, chronic obstructive pulmonary disease;
OHS, obesity hypoventilation syndrome; RTD, restrictive thoracic disor-
ders; FVC, forced vital capacity; PaCO2, partial pressure of carbon diox-
ide; PaO2, partial pressure of oxygen.
aNone with amyotrophic lateral sclerosis (ALS).
bBecause of low numbers, the 8–12 and 12–24 categories of this variable
were grouped together.
cBecause of low numbers, the three lowest categories of this variable
were grouped together.
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TABLE 2 Changes in HRQoL from 2008 to 2014 measured by The Severe Respiratory Insufficiency (SRI) questionnaire in the individuals





M (SD) Changea mean 95% CI p
Respiratory complaints 59 61.0 (22.4) 60 62.8 (20.8) 1.86 (3.19, 6.91) .46
Physical functioning 59 45.9 (23.0) 60 46.7 (23.4) 0.67 (4.07, 5.42) .78
Attendant symptoms and sleep 59 53.3 (20.1) 60 55.7 (21.6) 2.48 (2.14, 7.11) .29
Social relationships 59 70.7 (24.4) 60 79.1 (19.5) 8.47 (3.48, 13.5) .001
Anxieties 59 64.2 (27.5) 60 72.1 (22.9) 7.94 (2.42, 13.5) .006
Well-being 59 66.1 (22.0) 60 74.2 (17.0) 7.66 (3.28, 12.0) .001
Social functioning 59 56.5 (24.9) 60 62.4 (25.7) 5.89 (0.91, 10.9) .02
SUM score 59 60.0 (18.5) 60 64.8 (16.8) 4.74 (1.49, 8.00) .005
HRQoL, health-related quality of life; SD, standard deviation; CI, confidence interval.
aChange in SRI is estimated by linear mixed effects model with random intercept.







in meansa 95% CI p for change p for interaction
Background
Sex .88
Female 57.8 (16.1) 62.3 (15.0) 5.06 (0.30, 9.80) .04
Male 61.8 (20.0) 66.4 (18.0) 4.57 (0.21, 8.94) .04
Age .79
≤60 61.7 (16.2) 66.9(15.1) 5.25 (0.40, 10.1) .03
>60 58.7 (20.0) 62.7 (17.6) 4.37 (0.08, 8.66) .05
Education
Primary school 56.2 (20.8) 61.2 (19.1) 5.01 (0.74, 10.8) .09 .71
High school 56.0 (15.5) 61.7 (14.1) 6.16 (0.86, 11.4) .02
College/University 68.7 (16.8) 70.8 (15.9) 2.98 (2.76, 8.72) .30
Marital status .74
Married/cohabiting 59.9 (18.1) 64.9 (16.5) 5.25 (1.03, 9.48) .01
Single/divorced/widowed 60.2 (19.0) 64.0 (17.1) 4.17 (0.76, 9.11) .10
Years on LTMV .56
≤ 4 57.7(18.7) 63.0 (16.0) 5.65 (1.30, 9.99) .01
> 4 62.9 (17.8) 66.2 (17.5) 3.75 (1.00, 8.49) .12
Disease
NMD 62.8 (13.2) 65.2 (10.6) 3.2 (1.61, 8.00) .19 .14
COPD 51.1 (25.7) 48.5 (21.0) 2.6 (12.3, 7.06) .60
OHS 60.1 (20.2) 69.0 (18.5) 9.00 (3.85, 14.1) .001
RTD 57.8 (22.9) 61.6 (20.8) 3.83 (5.83, 13.5) .44
Treatment
LTMV h/dayb .88
5–8 61.0 (18.2 64.9(14.4) 4.51 (0.24, 8.77) .04
8–24 59.2 (19.6) 63.1(19.7) 4.02 (0.82, 8.88) .10
Dependency of daily assistance .76
No 60.9 (19.1) 65.4 (18.1) 4.56 (0.81, 8.31) .02
Yes 57.5 (16.2) 62.8 (12.4) 5.72 (0.54, 11.9) .07
Side effects of non-invasive LTMV .02
(Continues)
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3.4 | Explanatory variables associated with change
in HRQoL
Of 13 baseline characteristics evaluated as potential explanatory
variables for change in HRQoL from 2008 to 2014, five variables
were identified as significant factors for change in HRQoL. Side
effects of the non-invasive LTMV were significantly associated with
the total SRI score (Table 3) and SRI-Physical function (Table S1).
Satisfaction with LTMV training was associated with an improved
SRI-Psychological Well-Being score (Table 4). Satisfaction with fol-
low-up from healthcare professionals in the specialist health care
service was one explanatory variable for improvement in the SRI-
Anxiety score (Table 5). High age was one explanatory variable for a
lower SRI-Physical Function score (Table S1) and high FVC was cor-
related with improved HRQoL in the SRI- Social Functioning score
(Table S2).
4 | DISCUSSION
This study adds valuable new knowledge by being the first study to
examine the impact of 6 years of LTMV on HRQoL using the speci-
fic SRI questionnaire developed together with and for people treated
with LTMV. HRQoL improved both as measured by the total score
and by four of the seven SRI subdomains. The improvements
occurred in the clinically important domains ‘anxiety’, ‘social func-
tioning’, ‘social relationships’ and ‘psychological well-being’.
This study is also unique in that it identified explanatory vari-
ables possible for nurses to intervene on, aiming to achieve the main
goal of LTMV, which is to improve HRQoL. These results were
based on self-reported measures and as in most research on HRQoL,
the results may partly be explained by a better adaptation to living
with a chronic illness. However, a meta-analysis examining the clini-
cal significance of such an explanation, could not confirm this when
examining studies based on measures of response shift (Schwartz
et al., 2006).
4.1 | Patient evaluation of LTMV training and
follow-up as factors associated with changes in
HRQoL
The positive relationship between patient satisfaction with training
in the use of LTMV and improvement in the SRI-Psychological Well-
Being score is clinically important. It indicates that thorough basic
training in use of the ventilator and interfaces are vital success fac-








in meansa 95% CI p for change p for interaction
No 63.9 (20.1) 64.7 (18.8) 1.07 (3.38, 5.52) .64
Yes 56.2 (16.1) 65.1 (15.4) 8.89 (4.66, 13.1) <.001
Satisfactions with LTMV trainingc .09
Some satisfactionb 51.1 (15.2) 60.7 (16.2) 9.56 (1.69, 17.4) .02
Quite satisfied 55.2 (18.2) 62.7 (17.4) 8.06 (2.35, 13.8) .006
Very satisfied 65.1 (18.0) 67.0 (16.6) 1.80 (2.43, 6.03) .40
Satisfactions with follow-upc
Some satisfaction 57.0 (27.4) 63.8 (16.9 9.87 (0.13,19.6) .05 .24
Quite satisfied 53.1 (14.8) 60.0 (12.1) 6.90 (0.20, 13.6) .04
Very satisfied 66.4 (16.5) 68.5 (17.7) 2.01 (2.63, 6.65) .39
Respiratoryd
FVC (litre)
Per 1 unit increase 2.26 .17
PaCO2 kPa daytime
Per 1 unit increase 1.04 .62
PaO2, kPa daytime
Per 1 unit increase 1.67 .15
SRI-SS, severe respiratory insufficiency sum score; SD, standard deviation; CI, confidence interval; LTMV, long-term mechanical ventilation; NMD, neuro
muscular disease; COPD, chronic obstructive pulmonary disease; OHS, obesity hypoventilation syndrome; RTD, restrictive thoracic disorders; FVC,
forced vital capacity; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen.
aEstimated by mixed effects models, adjusted for background variables: sex, age, education, marital status, years on LTMV and disease.
bBecause of low numbers, the 8–12 and 12–24 categories of this variable were grouped together.
cBecause of low numbers, the three lowest categories of this variable were grouped together.
dFor continuous respiratory variables, data are presented as estimated change in SRI-SS for one unit increase (in the respiratory variables) and the corre-
sponding p for interaction.
658 | MARKUSSEN ET AL.












Female 65.8 (22.7) 73.4 (18.2) 7.91 (1.52, 14.3) .01
Male 66.6 (21.8) 74.5 (16.0) 7.44 (1.57, 13.3) .01
Age .96
≤60 66.8(21.7) 75.1(17.1) 7.73 (1.19, 14.2) .02
>60 65.8(22.6) 73.1 (17.0) 7.51 (1.74, 13.3) .01
Education .87
Primary school 60.3 (24.4) 69.4 (18.2) 9.18 (1.41, 16.9) .02
High school 62.9 (19.2) 70.4 (17.1) 7.49 (0.36, 14.6) .04
College/University 76.2 (20.2) 82.3 (12.6) 6.32 (1.42, 14.0) .11
Marital status .24
Married/cohabiting 65.1 (19.3) 75.1 (15.4) 9.85 (4.23, 15.5) .001
Single/divorce widowed 67.7 (25.4) 72.4 (19.0) 4.66 (1.90, 11.2) .16
Years on LTMV .43
≤4 63.4 (23.3) 73.2 (17,7) 9.21 (3.38, 15.0) .002
>4 69.7 (20.1) 74.9 (16.2) 5.72 (0.66, 12.1) .08
Disease .18
NMD 71.2 (16.6) 76.0 (13.0) 5.33 (1.18, 11.8) .12
COPD 62.0 (33.5) 60.6 (23.8) 1.39 (14.5, 11.7) .83
OHS 61.5 (23.7) 75.0 (18.8) 13.0 (6.07, 20.0) <.001
RTD 67.9 (23.0) 75.0 (16.1) 7.06 (6.03, 20.1) .29
Treatment
LTMV h/dayb .77
5–8 69.2 (21.8) 75.5 (15.9 6.65 (0.87, 12.4) .02
8–24 63.7 (22.7) 72.2 (18.8) 7.98 (1.39, 14.6) .02
Dependency of daily assistance .94
No 65.9, 22.3) 74.0 (18.4) 7.40 (1.02, 15.8) .08
Yes 67.2 (21.7) 73.6 (13.3) 7.76 (2.71, 12.8) .003
Side effects of non-invasive LTMV .15
No 67.2 (23.2) 72.1 (20.6) 11.2 (5.35, 17.1) <.001
Yes 64.6 (21.5) 75.9 (13.7) 4.87 (1.31, 11.0) .12
Satisfactions with LTMV trainingc .01
Some satisfaction 61.0 (16.0) 74.4 (11.8) 13.4 (3.13, 23.6) .01
Quite satisfied 58.5 (21.1) 72.5 (16.2) 14.8 (7.45, 22.2) <.001
Very satisfied 71.8 (22.8) 74.5 (19.1) 2.14 (3.35, 7.62) .45
Satisfactions with follow-upc .06
Some satisfaction 62.0 (27.2) 67.7 (14.3) 6.25 (6.23, 18.7) .32
Quite satisfied 60.0 (21.6) 74.6 (15.1) 14.5 (5.93, 23.1) .001
Very satisfied 74.2 (21.0) 76.7 (18.8) 1.78 (4.17, 7.74) .56
Respiratoryd
FVC (litre)
Per 1 unit increase 2.61 .27
PaCO2 kPa daytime
Per 1 unit increase 1.93 .52
(Continues)
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Patient satisfaction is related to the extent to which general
healthcare needs and condition-specific needs are met (Guldvog,
1999). The importance of giving proper training to a ventilator-
assisted individual is recognized as fundamental for good HRQoL.
However, it has not previously been well documented (Norregaard &
Escarrabill, 2010; p.172). According to Escarrabill (2015, p.282), the
competencies of the LTMV patient are directly related to the clinical
outcome. To our knowledge, no studies have focused on patient
training or education in patients receiving LTMV with HRQoL as a
primary outcome. A Cochrane review also concluded that there was
a small improvement in quality of life in COPD patients without
LTMV treatment who received a short patient training program com-
pared with those receiving usual care (Howcroft, Walters, Wood-
Baker, & Walters, 2016).
The SRI-Anxiety score was considerably improved both in the
overall analysis and in subanalysis of the different disease categories,
in line with the outcomes of other studies (K€ohnlein et al., 2014;
Struik et al., 2014; Windisch, 2008). The findings implicate that fol-
low-up from healthcare professionals might contribute to improve
the HRQoL of individuals receiving LTMV related to anxiety for
breathlessness. Furthermore, it might indicate that they feel safer
in situations where breathlessness may occur. According to Gibson,
Brooks, DeMatteo, and King (2009), it is especially important for
LTMV patients to have control over their day-to-day schedules, the
assistance provided and how it is carried out.
One of the challenges in clinical practice is to identify and target
the patients’ genuine needs (Leasa & Elson, 2016). There are differ-
ent approaches to follow-up. The setting for patient training and fol-
low-up in this study was a ‘real-world’ setting, including a multi and
interdisciplinary network model that shares and disseminates profes-
sional knowledge and skills in the field of LTMV. An evaluation of
management of DMD emphasizes the importance of multidisciplinary
care for these patients (Bushby et al., 2010). Escarbilrabill and Norre-
gaard (2010, p.179), also highlight the benefits of network models,
such as professional development and continuing education. An
important element of patient education and follow-up in ongoing
LTMV is the contact between patient and healthcare professionals
over several years, where patients and professionals identify and dis-
cuss problems caused by, or related to, the LTMV. The patient is
thus involved in the care process. This partnership might affect the
evaluation of and satisfaction with, the healthcare service. However,
the role of patient-reported outcomes measure (PROM) in facilitating
communication between healthcare professionals in the multidisci-
plinary team and the patient as a team member is yet to be explored
(Norekvaal, Faalun, & Fridlund, 2016).
4.2 | Patient-reported side effects as factors
associated with changes in HRQoL
Patient-reported side effects of non-invasive LTMV were signifi-
cantly associated with the total SRI score and the SRI-Physical func-
tion domain. To our knowledge, this study was the first to identify
side effects, such as soreness caused by mask pressure or air leakage
between the mask and face, were associated with a lower total SRI
score at baseline compared with those reporting no side effects.
According to Elliott (2004), some air leakage is an unavoidable con-
sequence of non-invasive LTMV. However, frequent side effects can
clearly worsen HRQoL or counteract the HRQoL benefits gained
from LTMV (Windisch, 2010, p. 585).
4.3 | Clinical data from the LTMV registry as
explanatory variables associated with changes in
HRQoL
High FVC was one explanatory variable for improved HRQoL in
terms of SRI-Social Functioning, a key domain because it indicates
improved leisure opportunities, including the ability to go out in the
evening and attend social events (Windisch et al., 2003). An explana-
tion of high FVC as clinically important factor might be that the
patients with higher FVC have more physical strength to carry out
the social functioning. Interaction between high FVC and improved
HRQoL are rarely reported. However, a weak but significant positive
association between pulmonary variables and HRQoL was also found
in patients with cystic fibrosis who were not treated with LTMV
(Hahn et al., 2007).
High age was an explanatory variable for a lower score for SRI-
Physical Function. This is in line with Huttmann et al. (2015), who
found reduced HRQoL in individuals receiving LTMV of higher age
and with chronic lung diseases, compared with younger patients with












Per 1 unit increase 2.93 .07
SRI-SS, severe respiratory insufficiency sum score; SD, standard deviation; CI, confidence interval; LTMV, long-term mechanical ventilation; NMD, neuro
muscular disease; COPD, chronic obstructive pulmonary disease; OHS, obesity hypoventilation syndrome; RTD, restrictive thoracic disorders; FVC,
forced vital capacity; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen.
aEstimated by mixed effects models, adjusted for background variables: sex, age, education, marital status, years on LTMV and disease.
bBecause of low numbers, the 8–12 and 12–24 categories of this variable were grouped together.
cBecause of low numbers, the three lowest categories of this variable were grouped together.
dFor continuous respiratory variables, data are presented as estimated change in SRI-SS for one unit increase (in the respiratory variables) and the corre-
sponding p for interaction.
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Female 63.9 (25.4) 73.6 (23.0) 9.9 (1.87, 17.9) .02
Male 64.4 (29.5) 70.7 (23.0) 6.3 (1.07, 13.7) .09
Age .96
≤60 63.9 (27.2) 71.7 (23.2) 7.79 (0.45, 16.0) .06
>60 64.4 (28.0) 72.3 (22.9) 8.05 (0.76, 15.3) .03
Education .22
Primary school 58.3 (27.0) 72.8 (24.6) 14.4 (4.70, 24.2) .004
High school 59.8 (27.3) 66.9 (23.7) 7.17 (1.61, 15.9) .11
College/University 74.9 (26.4) 77.6 (19.6) 2.76 (6.71, 12.2) .57
Marital status .53
Married/cohabiting 62.7 (29.1) 72.2 (21.9) 9.48 (2.31, 16.7) .01
Single/divorced/widowed 66.2 (25.5) 71.9 (24.5) 5.92 (2.42, 14.3) .16
Years on LTMV .59
≤4 60.7 (28.5) 70.0 (19.5) 9.28 (1.99, 16.6) .01
>4 68.6 (26.0) 74.6 (26.5) 6.26 (1.93, 14.4) .13
Disease .94
NMD 67.9 (24.0) 75.4 (16.0) 7.85 (0.63, 16.3) .07
COPD 48.3 (32.3) 52.5 (24.6) 4.17 (13.2, 21.5) .64
OHS 66.6 (27.4) 76.3 (25.8) 9.71 (0.63, 18.8) .04
RTD 55.8 (36.2) 61.7 (27.5) 5.83 (11.5, 23.2) .51
Treatment
LTMV h/dayb .40
5–8 64.5 (28.1) 73.5 (21.2) 9.28 (1.99, 16.6) .01
8–24 65.0 (27.8) 69.5 (25.5) 4.55 (1.93, 14.4) .27
Dependency of daily assistance .44
No 66.5 (26.7) 72.2 (24.2) 5.67 (0.19, 11.5) .06
Yes 61.4 (26.6) 71.2 (20.0) 10.2 (02.3, 20.1) .04
Side effects of non-invasive LTMV .15
No 69.8 28.1) 71.6 (25.1) 1.91 (5.07, 8.90) 1.92
Yes 62.3 (25.1) 71.4 (25.8) 9.09 (2.34, 15.8) .008
Satisfactions with LTMV trainingc .29
Some satisfaction 53.3 (26.2) 68.8 (23.4) 15.5 (2.83, 28.3) .02
Quite satisfied 61.8 (24.9) 68.9 (23.4) 7.35 (1.87, 16.6) .12
Very satisfied 70.3 (27.0) 74.5 (23.1) 4.18 (2.57, 10.9) .22
Satisfactions with follow-upc .009
Some satisfaction 49.5 (37.1) 75.0 (23.3) 26.9 (11.8, 41.9) <.001
Quite satisfied 53.1 (23.2) 66.5 (22.6) 13.5 (2.32, 24.6) .02
Very satisfied 73.6 (24.6) 75.3 (21.0) 1.69 (5.90, 9.29) .66
Respiratoryd
FVC (litre)
Per 1 unit increase 1.54 .60
PaCO2 kPa daytime
Per 1 unit increase 1.19 .75
(Continues)
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invasive LTMV >75 years had a significantly lower HRQoL measured
with SF-36 than patients <75 years.
Previous research has found improvements in the SRI scores
1 year after initiating LTMV in patients with severe COPD (K€ohn-
lein et al., 2014; Struik et al., 2014). One explanation of these dif-
ferences might be the progressive nature of some of the disease
categories might influence HRQoL more clearly in a 6-year study
than in a 1-year follow-up. The severity of COPD (GOLD 2017) is
also reflected in this study with a reduction in the total SRI score
and in five of seven SRI subdomains in the few surviving COPD
patients after 6 years in this study population. Huttmann et al.
(2015), also found reduced HRQoL in individuals receiving LTMV
with chronic lung diseases, compared with those with NMD. How-
ever, the ventilator pressure settings for these 60 patients were
lower compared with some of the other studies (Windisch, 2008;
K€ohnlein et al. (2014). Nevertheless, in this study we observed sig-
nificant reductions in carbon dioxide from before starting LTMV to
baseline in 2008, indicating good physiologic effect of the LTMV
treatment.
4.4 | Limitations of this study
The study has some limitations. Firstly, the study sample is relatively
small and heterogeneous in terms of the diagnoses leading to LTMV,
which means that the sample size is insufficient to perform subgroup
analyses, such as interaction studies between explanatory variables
and HRQoL for the specific subgroups, NMD, OHS, COPD or RTD.
Secondly, non-responders in 2008 had lower FVC than those who
attended, suggesting more severe disease and a lower HRQoL in the
non-participating group, which might influence the representative-
ness of the sample and generalizability of the result. However, infor-
mation about the physiological variables of non-participating LTMV
patients is a strength for the study. Recruiting patients from the
national registry also contributes to strengthen the representative-
ness of the sample and the generalizability of the result, even if the
coverage ratio in the registry was not 100%. Thirdly, there was no
control group in this study. Nonetheless, a RCT evaluation of HRQoL
in patients receiving LTMV vs. a non-ventilated control group of
patients would obviously be considered unethical. Despite the design
was unable to examine causal relationships, the study revealed clini-
cal important explanatory variables for improved HRQoL.
5 | CONCLUSION
This study adds important new knowledge by being the first study
to examine the impact of 6 years of ongoing LTMV on HRQoL using
the specific SRI questionnaire developed for and together with this
patient group. The total SRI score and the scores in four of the
seven subdomains improved in the majority of the patients treated
with LTMV. This study pointed out that patient training, follow-up
and reduction of side effects, a healthcare service largely delivered
by trained nurses, contribute to achieve the main goal of LTMV
treatment- improved HRQoL.
We recommend further prospective studies on HRQoL aspects
in LTMV, including standardized intervention models to minimize
side effects and to improve training, involvement and follow-up of
the patients. LTMV is an expensive treatment for few patients in the
community; to assure larger sample size we recommend international
cooperation and multicentre studies using the SRI questionnaire.
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Per 1 unit increase 2.18 .28
SRI-SS, severe respiratory insufficiency sum score; SD, standard deviation; CI, confidence interval; LTMV, long-term mechanical ventilation; NMD, neuro
muscular disease; COPD, chronic obstructive pulmonary disease; OHS, obesity hypoventilation syndrome; RTD, restrictive thoracic disorders; FVC,
forced vital capacity; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of oxygen.
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